The Seeding of Third World Science

Last August a contingent of US AIDS researchers visited Malawi, where health officials believe 20% of the urban population is HIV-infected. The investigators wanted to know if government leaders would allow citizens to take part in an AIDS vaccination trial set to begin later this year. When meeting with the nation's top three health ministers, the visiting scientists were surprised to find that each were former Fogarty International Center (FIC) fellows trained at Johns Hopkins University. "The

Written byBob Calandra
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The presence of Fogarty scholars shouldn't have surprised Beyrer. Johns Hopkins has been a part of the Center's campaign against AIDS in developing countries since its inception 14 years ago. During that time, Fogarty has underwritten the training of more than 2,000 developing world scientists in AIDS research at US universities. Other FIC fellows study other diseases. "We are devoting the major part of our resources to research and research training in developing countries where the burden of disease is greatest and the resources are the most limited," says Gerald T. Keusch, FIC director.

The Fogarty International Center is one of many industrialized country organizations that develop Third World scientists. The 24-country, 1,200-member European Molecular Biology Organization (EMBO) underwrites instruction, workshops, and lectures in molecular biology. It also offers long-term fellowships and operates a young investigator program, which encourages independent research. In May, EMBO will invite a new round of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies